Canada OKs Covidien's stroke revascularization device
Editorial Staff | December 13, 2012 | Cardiovascular Business | Vascular & Endovascular

Health Canada has approved Covidien's Solitaire FR revascularization device, which is used to restore blood flow to the brain in patients suffering from acute ischemic stroke.

According to the Canadian Stroke Network’s BURST (Burden of Ischemic Stroke) study, the healthcare costs for patients in the first six months after they have a stroke is more than $2.5 billion a year in Canada. This is a newer generation device, and it demonstrated positive outcomes over previous generation devices in two studies presented at this year's European Society of Cardiology (ESC), the SWIFT trial and the TREVO 2 trial.

The Solitaire FR device received CE Mark approval in Europe and has been sold in that region by Covidien since November 2009. Solitaire FR is also available in the U.S., where it received FDA clearance in March.

Editorial Staff

Related Content

Boston Scientific recalls premixed embolic agent after two deaths
Anemia may help explain why women are more likely to die during heart bypass surgery
FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices
FDA announces new recall of neurovascular catheters built by Johnson & Johnson subsidiary
GE Healthcare launching new AI software for handheld ultrasound system
New study provides ‘substantial evidence’ paclitaxel-coated devices are safe when treating lower-limb PAD

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup